1 Min Read
May 3 (Reuters) - Pfizer Inc
* Phase 3 Octave studies of oral tofacitinib in ulcerative colitis results published in the New England journal of medicine Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.